Rigel PharmaceuticalsRIGL
13F holders, Q1 2026 (March 31)9holders −1
1new positions
2sold out
$27.14avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 2 sold out. The largest holders were Hughes Financial Services, LLC ($43K), Farther Finance Advisors, LLC ($21K) and Advisory Services Network, LLC ($14K).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $297 |
| Exits | 2 | $12K |
All 13F filers, Q4 2025 → Q1 2026: 814 shares bought and 43,475 shares sold, net −42,661 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Hughes Financial Services, LLC | 0.01% | Add +59.8% | 1,600 | $43K |
| Farther Finance Advisors, LLC | 0.00% | Reduce -2.6% | 752 | $21K |
| Advisory Services Network, LLC | 0.00% | Reduce -98.8% | 501 | $14K |
| Versant Capital Management, Inc | 0.00% | Add +5.8% | 237 | $6K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +707.4% | 218 | $6K |
| Bare Financial Services, Inc | 0.00% | New | 11 | $297 |
| Essential Partners LLC | 0.00% | Reduce -60.0% | 4 | $108 |
| Rothschild Investment LLC | 0.00% | Reduce -87.5% | 1 | $27 |
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.